Summary
Dyskeratosis congenita (DC) is a rare congenital X-linked disorder. The major clinical manifestations are abnormal skin pigmentation, nail dystrophy, and leukoplakia of mucosal membranes. About 50% of the patients develop bone marrow failure, which is partly responsible for the poor prognosis. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) has been administered to some neutropenic patients with DC, but only a moderate stimulation of neutropoiesis has been observed. We report on a patient with DC treated with recombinant human granulocyte-colony-stimulating factor (rhG-CSF). This treatment resulted in a substantial dose-dependent increase in the neutrophil count.
Similar content being viewed by others
References
Bonilla MA, Gillio A, Ruggeiro M, Kernan N, Brachstein J, Abboud M, Fumagalli L, Vincent M, Gabrilove J, Welte K, Souza L, O'Reilly R (1989) Effects of recombinant human colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320:1574–1580
Colvin BT, Baker H, Hibbin JA, Gordon-Smith EC, Gordon MY (1984) Haematopoietic progenitor cells in dyskeratosis congenita. Br J Haematol 56:513–517
Connor JM, Gatherer D, Gray FC, Pirrit LA, Affara NA (1986) Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet 72:348
Dokal I, Bungey J, Williamson P, Oscier D, Hows J, Luzzato L (1992) Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood 80:3090–3096
Freund M, Luft St, Schöber Ch, Heussner P, Schrezenmaier H, Porzsolt F, Weite K (1990) Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Lancet 336:313
Friedland M, Lutton JD, Spitzer R, Levere RD (1985) Dyskeratosis congenita with hypoplastic anemia: a stem cell defect. Am J Hematol 20:85–87
Hess U, Ganser A, Schnurch HG, Seipelt G, Ottmann OG, Schulz G, Hoelzer D (1992) Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF). Br J Haematol 80:254–256
Marsch JCW, Will AJ, Hows JM, Sartori P, Darbyshire PJ, Williamson PJ, Oscier DG, Dexter M, Testa NG (1992) “Stem cell” origin of the hemopoietic defect in dyskeratosis congenita. Blood 79:3138–3144
Migliaccio AR, Migliaccio G, Dale DC, Hammond WP (1990) Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte-colony stimulating factor in vivo. Blood 75:1951–1959
Naoto A, Hiroyuki T, Hiroyuki N, Shigenori H, Izumi A, Shouji C (1990) rh G-CSF for Shwachman's syndrome. Lancet 336:1136
Putterman C, Safadi R, Zlotogora J, Banura R, Eldor A (1993) Treatment of the hematological manifestations of dyskeratosis congenita. Ann Hematol 66:209–212
Russo CL, Glader BE, Israel RJ, Galasso F (1990) Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor. Lancet 336:751–752
Schneider A, Mayer U, Gebhart E, Harma D, Gromball J, Glockell U, Beck JD (1988) Clastogen-induced fragility may differentiate pancytopenia of congenital dyskeratosis from Fanconi anemia. Eur J Pediatr 148:37
Schroter H, Roesler J, Breidenbach T, Wendel U, Elsner J, Schweitzer S, Zeidler C, Burdach S, Lohmann-Matthes ML, Wahn V, Welte K (1991) Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr 119:748–754
Teague RH, Connor JM (1981) Dyskeratosis congenita. Report of a large kindred. Br J Dermatol 105:321–325
Welte K, Zeidler C, Reiter A, Müller W, Odenwald E, Souza L, Riehm H (1990) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75:1056–1063
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oehler, L., Reiter, E., Friedl, J. et al. Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report. Ann Hematol 69, 325–327 (1994). https://doi.org/10.1007/BF01696564
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01696564